Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial.
Goshi NishimuraHiromitsu HatakeyamaOsamu ShionoMasataka TaguriMasanori KomatsuDaisuke SanoNaoko SakumaKenichiro YabukiYasuhiro AraiKunihiko ShibataYoshihiro ChibaTeruhiko TanabeNobuhiko OridatePublished in: JMIR research protocols (2018)
UMIN Clinical Trials Registry UMIN000031835; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ ctr_view.cgi?recptno=R000036355 (Archived by WebCite at http://www.webcitation.org/71fejVjMr).